UnknownPhase 4

Controlled Release of Oxycodone 10 mg In Pre-Medication For The Post Operative Analgesia In Elective Laparoscopic Bilateral Inguinal Hernia And Elective Laparoscopic Cholecystectomy

100 participantsStarted 2007-07

Plain-language summary

A Prospective Double Blind RCT: Controlled Release Oxycodone 10 mg On a 12 h Dosing Schedule Started With The Premedication ,Placebo Controlled Study,On Post Operative Analgesia Management in Laparoscopic Cholecystectomy and Laparoscopic Bilateral Inguinal Hernia (BIH). CRO is indicated for the management of moderate to severe pain when a continuous,around the clock analgesic is needed for an extended period of time.Its safety and efficacy in the first 12-24 hours post operative has not been established.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Local ethic committee approval * Written informed consent * ASA physical status I-III, scheduled for elective laparoscopic cholecystectomy and elective laparoscopic BIH Exclusion Criteria: * Difficulty in communication * Allergy to oxycodone and/or morphine * Allergy to local anesthetic * History of alcohol and substance abuse * Treated depression * Chronic use of opioid or tramadol or NSAIDS * Pregnancy * Obstructive sleep apnea * Anticipated fiber optic intubation * Severe hepatic or renal impairment * Weight \<50 kg or \> 100 kg * Conversion to laparotomy * Patient extubated in PACU. * Any prior abdominal surgery

Trial details

NCT IDNCT00480142

SponsorKaplan Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Contact for this trial

Oscar Liphshitz, MD

0524782736 liphshitz@clalit.org.il

View on ClinicalTrials.gov More Elective Laproscopic Bilateral Inguinal Hernia trials